Literature DB >> 1672193

Fetoplacental passage of 2',3'-dideoxyinosine.

J C Pons, M C Boubon, A M Taburet, E Singlas, V Chambrin, R Frydman, E Papiernik, J F Delfraissy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1672193     DOI： 10.1016/0140-6736(91)90313-e

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents.

Authors:  D M Burger; P L Meenhorst; J H Beijnen
Journal:  Pharm World Sci       Date:  1995-03-24

Review 2.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 3.  Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection.

Authors:  D Faulds; R N Brogden
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

Review 4.  Comparative pharmacokinetics of antiviral nucleoside analogues.

Authors:  G D Morse; M J Shelton; A M O'Donnell
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

5.  Transfer of dideoxyinosine across the human isolated placenta.

Authors:  G I Henderson; A B Perez; Y Yang; R L Hamby; R S Schenken; S Schenker
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.